156 related articles for article (PubMed ID: 38096193)
1. Circulating intermediate monocytes CD14++CD16+ are increased after elective percutaneous coronary intervention.
Merinopoulos I; Bhalraam U; Holmes T; Tsampasian V; Corballis N; Gunawardena T; Sawh C; Maart C; Wistow T; Ryding A; Eccleshall SC; Smith J; Vassiliou VS
PLoS One; 2023; 18(12):e0294746. PubMed ID: 38096193
[TBL] [Abstract][Full Text] [Related]
2. Lower HDL-C levels are associated with higher expressions of CD16 on monocyte subsets in coronary atherosclerosis.
Xiang Y; Liang B; Zhang X; Zheng F
Int J Med Sci; 2020; 17(14):2171-2179. PubMed ID: 32922178
[No Abstract] [Full Text] [Related]
3. CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography.
Rogacev KS; Cremers B; Zawada AM; Seiler S; Binder N; Ege P; Große-Dunker G; Heisel I; Hornof F; Jeken J; Rebling NM; Ulrich C; Scheller B; Böhm M; Fliser D; Heine GH
J Am Coll Cardiol; 2012 Oct; 60(16):1512-20. PubMed ID: 22999728
[TBL] [Abstract][Full Text] [Related]
4. The "Intermediate" CD14
Wildgruber M; Aschenbrenner T; Wendorff H; Czubba M; Glinzer A; Haller B; Schiemann M; Zimmermann A; Berger H; Eckstein HH; Meier R; Wohlgemuth WA; Libby P; Zernecke A
Sci Rep; 2016 Dec; 6():39483. PubMed ID: 27991581
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Activated Monocytes in Patients with ST-Elevation Myocardial Infarction.
Abo-Aly M; Shokri E; Chelvarajan L; Tarhuni WM; Tripathi H; Abdel-Latif A
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511100
[TBL] [Abstract][Full Text] [Related]
6. Circulating intermediate CD14++CD16+monocytes are increased in patients with atrial fibrillation and reflect the functional remodelling of the left atrium.
Suzuki A; Fukuzawa K; Yamashita T; Yoshida A; Sasaki N; Emoto T; Takei A; Fujiwara R; Nakanishi T; Yamashita S; Matsumoto A; Konishi H; Ichibori H; Hirata KI
Europace; 2017 Jan; 19(1):40-47. PubMed ID: 26826137
[TBL] [Abstract][Full Text] [Related]
7. CD16(+) monocyte subsets are increased in large abdominal aortic aneurysms and are differentially related with circulating and cell-associated biochemical and inflammatory biomarkers.
Ghigliotti G; Barisione C; Garibaldi S; Brunelli C; Palmieri D; Spinella G; Pane B; Spallarossa P; Altieri P; Fabbi P; Sambuceti G; Palombo D
Dis Markers; 2013; 34(2):131-42. PubMed ID: 23348634
[TBL] [Abstract][Full Text] [Related]
8. The role of monocyte phenotype switching in peri-procedural myocardial injury and its involvement in statin therapy.
Yang Y; Cui Y; Peng DQ
Med Sci Monit; 2013 Nov; 19():1006-12. PubMed ID: 24241246
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the CD14++CD16+ monocyte population in human bone marrow.
Mandl M; Schmitz S; Weber C; Hristov M
PLoS One; 2014; 9(11):e112140. PubMed ID: 25369328
[TBL] [Abstract][Full Text] [Related]
10. A Novel, Five-Marker Alternative to CD16-CD14 Gating to Identify the Three Human Monocyte Subsets.
Ong SM; Teng K; Newell E; Chen H; Chen J; Loy T; Yeo TW; Fink K; Wong SC
Front Immunol; 2019; 10():1761. PubMed ID: 31402918
[TBL] [Abstract][Full Text] [Related]
11. The Kinetics of Circulating Monocyte Subsets and Monocyte-Platelet Aggregates in the Acute Phase of ST-Elevation Myocardial Infarction: Associations with 2-Year Cardiovascular Events.
Zhou X; Liu XL; Ji WJ; Liu JX; Guo ZZ; Ren D; Ma YQ; Zeng S; Xu ZW; Li HX; Wang PP; Zhang Z; Li YM; Benefield BC; Zawada AM; Thorp EB; Lee DC; Heine GH
Medicine (Baltimore); 2016 May; 95(18):e3466. PubMed ID: 27149446
[TBL] [Abstract][Full Text] [Related]
12. The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction.
Tapp LD; Shantsila E; Wrigley BJ; Pamukcu B; Lip GY
J Thromb Haemost; 2012 Jul; 10(7):1231-41. PubMed ID: 22212813
[TBL] [Abstract][Full Text] [Related]
13. Circulating CD14
Meeuwsen JAL; de Vries JJ; van Duijvenvoorde A; van der Velden S; van der Laan SW; van Koeverden ID; van de Weg SM; de Borst GJ; de Winther MPJ; Kuiper J; Pasterkamp G; Hoefer IE; de Jager SCA;
J Mol Cell Cardiol; 2019 Feb; 127():260-269. PubMed ID: 30629987
[TBL] [Abstract][Full Text] [Related]
14. Admission Low-Density Lipoprotein Cholesterol Stratified by Circulating CD14++CD16+ Monocytes and Risk for Recurrent Cardiovascular Events Following ST Elevation Myocardial Infarction: Lipid Paradox Revised.
Dong S; Ji W; Zeng S; Miao J; Yan L; Liu X; Liu J; Zhou X; Yang Q
J Cardiovasc Transl Res; 2020 Dec; 13(6):916-927. PubMed ID: 32557321
[TBL] [Abstract][Full Text] [Related]
15. Maximal Exercise Alters the Inflammatory Phenotype and Response of Mononuclear Cells.
Slusher AL; Zúñiga TM; Acevedo EO
Med Sci Sports Exerc; 2018 Apr; 50(4):675-683. PubMed ID: 29112629
[TBL] [Abstract][Full Text] [Related]
16. Elevated circulating CD14
Peng A; Ke P; Zhao R; Lu X; Zhang C; Huang X; Tian G; Huang J; Wang J; Invernizzi P; Chen Q; Zhuang J
Clin Exp Med; 2016 Nov; 16(4):511-521. PubMed ID: 26403460
[TBL] [Abstract][Full Text] [Related]
17. CD14++CD16+ Monocytes Are Enriched by Glucocorticoid Treatment and Are Functionally Attenuated in Driving Effector T Cell Responses.
Liu B; Dhanda A; Hirani S; Williams EL; Sen HN; Martinez Estrada F; Ling D; Thompson I; Casady M; Li Z; Si H; Tucker W; Wei L; Jawad S; Sura A; Dailey J; Hannes S; Chen P; Chien JL; Gordon S; Lee RW; Nussenblatt RB
J Immunol; 2015 Jun; 194(11):5150-60. PubMed ID: 25911752
[TBL] [Abstract][Full Text] [Related]
18. Human Blood Monocyte Subsets: A New Gating Strategy Defined Using Cell Surface Markers Identified by Mass Cytometry.
Thomas GD; Hamers AAJ; Nakao C; Marcovecchio P; Taylor AM; McSkimming C; Nguyen AT; McNamara CA; Hedrick CC
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1548-1558. PubMed ID: 28596372
[TBL] [Abstract][Full Text] [Related]
19. Differential in vivo activation of monocyte subsets during low-grade inflammation through experimental endotoxemia in humans.
Thaler B; Hohensinner PJ; Krychtiuk KA; Matzneller P; Koller L; Brekalo M; Maurer G; Huber K; Zeitlinger M; Jilma B; Wojta J; Speidl WS
Sci Rep; 2016 Jul; 6():30162. PubMed ID: 27444882
[TBL] [Abstract][Full Text] [Related]
20. ADAM17-Mediated Reduction in CD14
Waller K; James C; de Jong A; Blackmore L; Ma Y; Stagg A; Kelsell D; O'Dwyer M; Hutchins R; Alazawi W
Front Immunol; 2019; 10():1902. PubMed ID: 31507587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
